Your browser doesn't support javascript.
loading
Targeted therapies for ROS1-rearranged non-small cell lung cancer.
Patil, T; Simons, E; Mushtaq, R; Pacheco, J M; Doebele, R C; Bowles, D W.
Affiliation
  • Patil T; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Simons E; Division of General Internal Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Mushtaq R; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Pacheco JM; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Doebele RC; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Bowles DW; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. daniel.bowles@ucdenver.edu.
Drugs Today (Barc) ; 55(10): 641-652, 2019 Oct.
Article in En | MEDLINE | ID: mdl-31720561
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Protein-Tyrosine Kinases / Proto-Oncogene Proteins / Carcinoma, Non-Small-Cell Lung / Molecular Targeted Therapy / Lung Neoplasms Limits: Humans Language: En Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Protein-Tyrosine Kinases / Proto-Oncogene Proteins / Carcinoma, Non-Small-Cell Lung / Molecular Targeted Therapy / Lung Neoplasms Limits: Humans Language: En Year: 2019 Type: Article